Amedisys, Inc. (AMED) Misses Q1 EPS by 3c

Amedisys, Inc. (NASDAQ: AMED) reported Q1 EPS of ($0.07), $0.03 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $298.74 million versus the consensus estimate of $301.89 million.

For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Holcim to acquire Fermacell from James Hardie for EUR 840M
• Citi cuts Weibo stock rating to Neutral, lowers price target